The current status of seizure duration in the practice of electroconvulsive therapy

Canadian Journal of Psychiatry

Volumn 41, Issue 5, 1996, Pages 299-304

  Lalla, Fiore R ^a   Milroy, Thomas ^b  

^a MCGILL UNIVERSITY   (Canada)

^b MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

anesthesia; benzodiazep ines; caffeine; efficacy; electroconvulsive therapy; lidocaine; medication; seizure duration

Indexed keywords

ANESTHETIC AGENT; BENZODIAZEPINE DERIVATIVE; CAFFEINE; LIDOCAINE; METHOHEXITAL; OXYTOCIN; PROLACTIN; PROPOFOL;

ARTICLE; CLINICAL TRIAL; DEPRESSION; ELECTROCONVULSIVE THERAPY; ELECTROENCEPHALOGRAM; HORMONE RELEASE; HUMAN; SEIZURE; TIME; TREATMENT OUTCOME;

EID: 0029902133     PISSN: 07067437     EISSN: None     Source Type: Journal    
DOI: 10.1177/070674379604100507     Document Type: Article

References (75)

1. Fink M. Impact of the anti-psychiatry movement on the revival of electroconvulsive therapy in the United States. Psychiatr Clin North Am 1991;14:793-801.
2. Devanand DP, Dwork AJ, Hutchison ER, and others. Does ECT alter brain structure? Am J Psychiatry 1994;151:957-70.
3. Fink M. The next challenge: the mode of action of ECT. Convuls Ther 1993;9:192-7.
4. American Psychiatric Association. Electroconvulsive therapy: task force report 14. Washington (DC): American Psychiatric Association; 1978.
5. Mukherjee S. Mechanisms of the antimanic effect of electroconvulsive therapy. Convuls Ther 1989:5;337-43.
6. Ottosson JO. Experimental studies of the mode of action of electroconvulsive therapy. Acta Psychiatr Scand Suppl 1960;145:1-141.
7. Sackeim HA. Mechanisms of action of electroconvulsive therapy. In: Hales RE, Frances J, editors. Volume 7, Annual review of psychiatry. Washington: American Psychiatric Press; 1988.
8. Sackeim HA. Mechanisms of action. Convuls Ther 1989;6:207-310.
9. Sackeim HA, Mukherjee S. Neurophysiological variability in the effects of the ECT stimulus. Convuls Ther 1986;2:267-76.
10. Krystal AD, Weiner RD. ECT seizure therapeutic adequacy. Convuls Ther 1994;19:153-64.
11. Meduna IJ. Autobiography of IJ Meduna (Part 2). Convuls Ther 1985;1:43-57.
12. Kalinowsky L, Barrera E. Electric convulsion therapy in mental disorders. Psychiatr Q 1940;14:719-30.
13. Kalinowsky LB, Hoch PH. Shock treatments and other somatic procedures in psychiatry. New York: Grune & Stratton; 1946.
14. Cerletti U. Electroschock therapy. In: Sackler AM, Sackler MD, Sackler RR, Marti-Ibanez F, editors. The great physiodynamic therapies in psychiatry. New York: Hoeber-Harper; 1956.
15. Androp S. Electric shock therapy in the psychoses: convulsive and subconvulsive methods. Psychiatr Q 1941;16:730-49.
16. Lowenbach II. Electric shock treatment of mental disorders. N C Med J 1943;4:123-8.
17. Sackeim HA, Devanand DP, Prudic J. Stimulus intensity, seizure threshold, and seizure duration: impact on the efficacy and safety of electroconvulsive therapy. Psychiatr Clin North Am 1991;14:803-43.
18. Ottosson JO. Effect of lidocaine on the seizure discharge in electroconvulsive therapy. Acta Psychiatr Scand Suppl 1960;145:7-32.
19. Standish-Barry HM, Deacon V, Snaith RP. The relationship of concurrent benzodiazepine administration to seizure duration in ECT. Acta Psychiatr Scand 1985;71:269-71.
20. Pettinati HM, Willis KW, Nilsen SM, and others. Benzodiazepines reduce ECTs therapeutic effect [abstract]. In: Abstracts of the 140th annual meeting of the American Psychiatric Association; 1987 May 7-13.
21. Bowen RC. The effect of diazepam on endogenously depressed patients. J Clin Pharmacol 1978;18:280-4.
22. Greenberg RM, Pettinati HM Benzodiazepines and electroconvulsive therapy. Convuls Ther 1993;9:262-73.
23. Maletzky BM. Seizure duration and clinical effect in electroconvulsive therapy. Compr Psychiatry 1978;19:541-80.
24. Zorumski CF, Burke WJ, Rutherford JL, and others. ECT: clinical variables, seizure duration and outcome. Convuls Ther 1986;2:109-19.
25. Abrams RA. Hypothesis to explain divergent findings among studies comparing the efficacy of unilateral and bilateral ECT in depression. Convuls Ther 1986;2:253-7.
26. Abrams R, Fink M. Clinical experience with multiple electroconvulsive treatments. Compr Psychiatry 1972;13:115-21.
27. Blachly PH, Gowing D. Multiple monitored electroconvulsive treatment. Compr Psychiatry 1966;7:100-9.
28. Cromholm B, Ottosson JO. Ultrabrief stimulus technique in electroconvulsive therapy II: comparative studies on therapeutic effects and memory disturbances in treatment of endogenous depression with the Either ES electroshock apparatus and the Siemens Konvulsator III. J Nerv Ment Dis 1963;137:268-76.
29. d'Elia O, Ottosson JO, Strömgren L. Present practice of electroconvulsive therapy in Scandinavia. Arch Gen Psychiatry 1953;40:577-81.
30. d'Elia G, Perris C. Comparison of electroconvulsive therapy with unilateral and bilateral stimulation. Acta Psychiatr Scand 1970;215:9-29.
31. d'Elia G, Raotma H. Is unilateral ECT less effective than bilateral ECT? Br J Psychiatry 1975;126;83-9.
32. Fink M. Missed seizures and the bilateral-unilateral electroconvulsive therapy controversy. Am J Psychiatry 1983;140:198-9.
33. Heshe J, Roder E, Theilgaard A. Unilateral and bilateral ECT: a psychiatric and psychological study of therapeutic effect and side effects. Acta Psychiatr Scand 1978;275(Suppl):1S-180S.
34. Miller AL, Faber RA, Hatch JP, and others. Factors affecting amnesia, seizure duration, efficacy in ECT. Am J Psychiatry 1985;142:692-6.
35. Ottosson JO. Is unilateral nondominant ECT as efficient as bilateral ECT? a new look at the evidence. Convuls Ther 1991;7:190-200.
36. Overall JI, Rhoades HM. A comment on the efficacy of unilateral versus bilateral ECT. Convuls Ther 1986;3:245-51.
37. Pettinati HM, Nilsen S. Missed and brief seizures during ECT: differential response between unilateral and bilateral electrode placement. Biol Psychiatry 1985;20:506-14.
38. Sackeim HA. Optimizing unilateral electroconvulsive therapy. Convuls Ther 1991;7:201-12.
39. Sackeim HA, Decina P, Kanzler M, and others. Effects of electrode placement on the efficacy of titrated, low-dose ECT. Am J Psychiatry 1987;144:1449-55.
40. Sackeim HA, Decina P, Portnoy S, and others. Studies of dosage, seizure threshold, and seizure duration in ECT. Biol Psychiatry 1987;22:249-68.
41. Weiner RD, Coffey CE. Minimizing therapeutic differences between bilateral and unilateral nondominant ECT. Convuls Therapy 1986;2:261-5.
42. Enderle JD, Staton JD, Gerst J, and others. The electroencephalographic pattern during electroconvulsive therapy III: analysis of frontotemporal and nasopharyngeal spectral energy. Clin Electroencephalogr 1986;17:66-77.
43. Krystal AD, Weiner RD, McCall WW, and others. The effects of ECT stimulus dose and electrode placement on the ictal electroencephalogram: an intraindividual crossover study. Biol Psychiatry 1993;34:759-67.
44. Kirstein I,-Ottosson JO. Experimental studies of the electroencephalographic changes following electroconvulsive therapy. Acta Psychiatr Scand Suppl 1960;145:49-68.
45. Abrams R, Swartz CM. Electroconvulsive therapy and prolactin release: relation to treatment response in melancholia. Convuls Ther 1985;1:38-42.
46. Swartz CM. Beyond seizure duration as a measure of treatment quality. Convuls Ther 1993;9:1-7.
47. Abrams R, Swartz CM. Electroconvulsive therapy and prolactin release: effects of stimulus parameters. Convuls Ther 1985;1:115-9.
48. Whalley IJ, Dick H, Watts AG, and others. Immediate increases in plasma prolactin and neurophysin but not other hormones after electroconvulsive therapy. Lancet 1982;1064-8.
49. Scott AIF, Whalley LJ, Legros J-I. Treatment outcome, seizure duration, and the neurophysin response to ECT. Biol Psychiatry 1989;25:585-97.
50. Sackeim HA, Prudic J, Devanand DP, and others. Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects electroconvulsive therapy. N Engl J Med 1993;328:839-46.
51. Sackeim HA, Decina P, Prohovnik I, and others. Dosage, seizure threshold, and the antidepressant efficacy of electroconvulsive therapy. Ann N Y Acad Sci 1986;462:398-410.
52. Fink M. What is an adequate treatment in convulsive therapy? Acta Psychiatr Scand 1991;84:424-7.
53. Fink M. An adequate treatment? Convuls Ther 1989;5:311-3.
54. Abrams R, Volavka J, Fink M. EEG seizure patterns during multiple unilateral and bilateral ECT. Compr Psychiatry 1973;14:25-8.
55. Robin A, de Tissera S. A double-blind controlled comparison of the therapeutic effects of low and high energy electroconvulsive therapies. Br J Psychiatry 1982;141:357-66.
56. Green AR, Butt D, Cowen P. Increased seizure threshold following convulsion. In Sandier M, editor. Psychopharmacology of anticonvulsants. Oxford: Oxford University Press; 1982.
57. Post RM, Putnam F, Uhde TW, and others. Electroconvulsive therapy as an anticonvulsant: implications for its mechanism of action in affective illness. Ann N Y Acad Sci 1986;462:376-88.
58. Krystal AD, Weiner RD, Coffey CE, and others. EEG evidence of more "intense" seizure activity with bilateral ECT. Biol Psychiatry 1992;31:617-21.
59. Nobler MS, Sackeim HA, Solomon M, and others. EEG manifestations during ECT: effects of electrode placement and stimulus intensity. Biol Psychiatry 1993;34:321-30.
60. Fink M, Nemeroff CB. A neuroendocrine view of ECT. Convuls Ther 1989;5:269-304.
61. Fink M, Ottosson JO. A theory of convulsive therapy in endogenous depression: significance of hypothalamic function. Psychiatry Res 1980;2:49-61.
62. Lerer B. Neurochemical and other neurobiological consequences of ECT: implications for the pathogenesis and treatment of affective disorders. In: Meltzer HY, editor. Psychopharmacology: the third generation of progress. New York: Raven Press; 1987.
63. Cohen SJ, Lawton C. Do benzodiazepines interfere with the action of electroconvulsive therapy? Br J Psychiatry 1992;160:545-6.
64. Green AR. Do benzodiazepines interfere with the action of electroconvulsive therapy? Br J Psychiatry 1992;161:129-30.
65. Ottosson JO. Seizure characteristics and therapeutic efficiency in electroconvulsive therapy: an analysis of the antidepressive efficiency of grand mal and lidocaine-modified seizures. J Nerv Ment Dis 1962;135:239-51.
66. Fear CF, Littlejohns CS, Rouse E, and others. Propofol anaesthesia in electroconvulsive therapy. Br J Psychiatry 1994;165:506-9.
67. American Psychiatric Association. The practice of electroconvulsive therapy: recommendations for treatment, training and privileging: a task force report. Washington (DC): American Psychiatric Association Press; 1990.
68. Malsch E, Gratz I, Mani S, and others. Efficacy of electroconvulsive therapy after propofal and pethotexital anesthesia. Convuls Ther 1994;10:212-9.
69. Pettinati HM, Stephens SM, Willis KM, and others. Evidence for less improvement in depression in patients taking benzodiazepines during unilateral ECT. Am J Psychiatry 1990;147:1029-35.
70. Strömgren LS, Dal J, Fjeldgerg N, and others. Factors influencing seizure duration and number of seizures applied in unilateral electroconvulsive therapy. Acta Psychiatr Scand 1980;62:158-65.
71. McCall WV, Reid S, Rosenquist P, and others. A reappraisal of the role of caffeine in ECT. Am J Psychiatry 1993;150:1543-45.
72. Coffey DE, Figiel GS, Weiner RD, and others. Caffeine augmentation of ECT. Am J Psychiatry 1990;147:579-85.
73. Rosenquist PB, McCall WV, Farah A, and others. Effects of caffeine pretreatment on measures of seizure impact. Convuls Ther 1994;10:181-5.
74. Daniel WF, Crovitz HF. Acute memory impairment following electroconvulsive therapy, 1: effects of electrical stimulus waveform and number of treatments. Acta Psychiatr Scand 1983;67:1-7.
75. Daniel WF, Crovitz HF. Recovery of orientation after electroconvulsive therapy. Acta Psychiatr Scand 1982;66:421-44.